TY - JOUR
T1 - Health system modelling research
T2 - towards a whole-health-system perspective for identifying good value for money investments in health system strengthening
AU - Verguet, Stéphane
AU - Feldhaus, Isabelle
AU - Jiang Kwete, Xiaoxiao
AU - Aqil, Anwer
AU - Atun, Rifat
AU - Bishai, David
AU - Cecchini, Michele
AU - Guerra Junior, Augusto Afonso
AU - Habtemariam, Mahlet Kifle
AU - Jbaily, Abdulrahman
AU - Karanfil, Ozge
AU - Kruk, Margaret E.
AU - Haneuse, Sebastien
AU - Norheim, Ole Frithjof
AU - Smith, Peter C.
AU - Tolla, Mieraf Taddesse
AU - Zewdu, Solomon
AU - Bump, Jesse
N1 - © Author(s) (or their employer(s)) 2019.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Global health research has typically focused on single diseases, and most economic evaluation research to date has analysed technical health interventions to identify 'best buys'. New approaches in the conduct of economic evaluations are needed to help policymakers in choosing what may be good value (ie, greater health, distribution of health, or financial risk protection) for money (ie, per budget expenditure) investments for health system strengthening (HSS) that tend to be programmatic. We posit that these economic evaluations of HSS interventions will require developing new analytic models of health systems which recognise the dynamic connections between the different components of the health system, characterise the type and interlinks of the system's delivery platforms; and acknowledge the multiple constraints both within and outside the health sector which limit the system's capacity to efficiently attain its objectives. We describe priority health system modelling research areas to conduct economic evaluation of HSS interventions and ultimately identify good value for money investments in HSS.
AB - Global health research has typically focused on single diseases, and most economic evaluation research to date has analysed technical health interventions to identify 'best buys'. New approaches in the conduct of economic evaluations are needed to help policymakers in choosing what may be good value (ie, greater health, distribution of health, or financial risk protection) for money (ie, per budget expenditure) investments for health system strengthening (HSS) that tend to be programmatic. We posit that these economic evaluations of HSS interventions will require developing new analytic models of health systems which recognise the dynamic connections between the different components of the health system, characterise the type and interlinks of the system's delivery platforms; and acknowledge the multiple constraints both within and outside the health sector which limit the system's capacity to efficiently attain its objectives. We describe priority health system modelling research areas to conduct economic evaluation of HSS interventions and ultimately identify good value for money investments in HSS.
KW - economic evaluation
KW - health system modelling
KW - health system strengthening
UR - http://www.scopus.com/inward/record.url?scp=85065086567&partnerID=8YFLogxK
U2 - 10.1136/bmjgh-2018-001311
DO - 10.1136/bmjgh-2018-001311
M3 - Article
AN - SCOPUS:85065086567
SN - 2059-7908
VL - 4
JO - BMJ Global health
JF - BMJ Global health
IS - 2
M1 - e001311
ER -